» Articles » PMID: 21854280

Some Considerations for Excess Zeroes in Substance Abuse Research

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 2011 Aug 23
PMID 21854280
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Count data collected in substance abuse research often come with an excess of "zeroes," which are typically handled using zero-inflated regression models. However, there is a need to consider the design aspects of those studies before using such a statistical model to ascertain the sources of zeroes.

Objectives: We sought to illustrate hurdle models as alternatives to zero-inflated models to validate a two-stage decision-making process in situations of "excess zeroes."

Methods: We use data from a study of 45 cocaine-dependent subjects where the primary scientific question was to evaluate whether study participation influences drug-seeking behavior. The outcome, "the frequency (count) of cocaine use days per week," is bounded (ranging from 0 to 7). We fit and compare binomial, Poisson, negative binomial, and the hurdle version of these models to study the effect of gender, age, time, and study participation on cocaine use.

Results: The hurdle binomial model provides the best fit. Gender and time are not predictive of use. Higher odds of use versus no use are associated with age; however once use is experienced, odds of further use decrease with increase in age. Participation was associated with higher odds of no-cocaine use; once there is use, participation reduced the odds of further use.

Conclusion: Age and study participation are significantly predictive of cocaine-use behavior.

Scientific Significance: The two-stage decision process as modeled by a hurdle binomial model (appropriate for bounded count data with excess zeroes) provides interesting insights into the study of covariate effects on count responses of substance use, when all enrolled subjects are believed to be "at-risk" of use.

Citing Articles

Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.

Charron E, Brooks J, Peterson K, Akinwolere O, Winhusen T, Cochran G Res Social Adm Pharm. 2023; 19(8):1171-1177.

PMID: 37142474 PMC: 10523937. DOI: 10.1016/j.sapharm.2023.04.121.


Studying dietary intake in daily life through multilevel two-part modelling: a novel analytical approach and its practical application.

Ruf A, Neubauer A, Ebner-Priemer U, Reif A, Matura S Int J Behav Nutr Phys Act. 2021; 18(1):130.

PMID: 34579744 PMC: 8477527. DOI: 10.1186/s12966-021-01187-8.


The role of negative emotional reactivity and neighborhood factors in predicting marijuana use during early adolescence.

Tache R, Rabinowitz J, Gepty A, Lambert S, Reboussin B, Reynolds M J Adolesc. 2020; 85:32-40.

PMID: 33038686 PMC: 9109817. DOI: 10.1016/j.adolescence.2020.09.002.


Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions.

DeSantis S, Li R, Zhang Y, Wang X, Vernon S, Tilley B Clin Trials. 2020; 17(6):627-636.

PMID: 32838555 PMC: 9497422. DOI: 10.1177/1740774520936668.


Pilot trial investigating a brief behavioral economic intervention as an adjunctive treatment for alcohol use disorder.

Meshesha L, Soltis K, Wise E, Rohsenow D, Witkiewitz K, Murphy J J Subst Abuse Treat. 2020; 113:108002.

PMID: 32359674 PMC: 7198610. DOI: 10.1016/j.jsat.2020.108002.


References
1.
Hien D, Campbell A, Killeen T, Hu M, Hansen C, Jiang H . The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study. AIDS Behav. 2009; 14(2):421-30. PMC: 2835800. DOI: 10.1007/s10461-009-9573-7. View

2.
Rose C, Martin S, Wannemuehler K, Plikaytis B . On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data. J Biopharm Stat. 2006; 16(4):463-81. DOI: 10.1080/10543400600719384. View

3.
Comulada W, Weiss R, Cumberland W, Rotheram-Borus M . Reductions in drug use among young people living with HIV. Am J Drug Alcohol Abuse. 2007; 33(3):493-501. PMC: 2819808. DOI: 10.1080/00952990701301921. View

4.
Moulton L, Curriero F, Barroso P . Mixture models for quantitative HIV RNA data. Stat Methods Med Res. 2002; 11(4):317-25. DOI: 10.1191/0962280202sm292ra. View

5.
Booth R, Watters J, Chitwood D . HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health. 1993; 83(8):1144-8. PMC: 1695160. DOI: 10.2105/ajph.83.8.1144. View